Amedeo's Top 20

Amedeo Smart

Independent Medical Education

28 January 2019

Multidisciplinary Journal Club

  1. Tshilolo L, Tomlinson G, Williams TN, Santos B, et al.
    Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
    N Engl J Med 2018.

  1. Llanos-Cuentas A, Lacerda MVG, Hien TT, Velez ID, et al.
    Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    N Engl J Med 2019;380:229-241.

  2. McDermott DH, Pastrana DV, Calvo KR, Pittaluga S, et al.
    Plerixafor for the Treatment of WHIM Syndrome.
    N Engl J Med 2019;380:163-170.

  3. Costello SP, Hughes PA, Waters O, Bryant RV, et al.
    Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    JAMA 2019;321:156-164.

  4. Brown JWL, Coles A, Horakova D, Havrdova E, et al.
    Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
    JAMA 2019;321:175-187.

  1. .
    Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial.
    Lancet 2019.

  2. Cohen PA, Jhingran A, Oaknin A, Denny L, et al.
    Cervical cancer.
    Lancet 2019;393:169-182.

  3. Antonia SJ, Villegas A, Daniel D, Vicente D, et al.
    Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
    N Engl J Med 2018;379:2342-2350.

  4. Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, et al.
    Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    N Engl J Med 2019;380:215-228.

  5. Panza F, Lozupone M, Seripa D, Imbimbo BP, et al.
    Amyloid-beta Immunotherapy for Alzheimer's Disease - Is It Now A Long Shot...?
    Ann Neurol 2019.

  1. Woyach JA, Ruppert AS, Heerema NA, Zhao W, et al.
    Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
    N Engl J Med 2018;379:2517-2528.

  2. Honce JM, Nair KV, Sillau S, Valdez B, et al.
    Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.
    Neurology 2019.

  3. Blomquist JL, Munoz A, Carroll M, Handa VL, et al.
    Association of Delivery Mode With Pelvic Floor Disorders After Childbirth.
    JAMA 2018;320:2438-2447.

  4. Nigwekar SU, Nazarian RM.
    Cutaneous calcification in patients with kidney disease is not always calciphylaxis.
    Kidney Int 2018;94:244-246.

  5. Burt RK, Balabanov R, Burman J, Sharrack B, et al.
    Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
    JAMA 2019;321:165-174.

  1. Marrodan M, Alessandro L, Farez MF, Correale J, et al.
    The role of infections in multiple sclerosis.
    Mult Scler 2019.

  2. Poinen K, Quinn RR, Clarke A, Ravani P, et al.
    Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.
    Am J Kidney Dis 2019.

  3. Huybrechts KF, Hernandez-Diaz S, Straub L, Gray KJ, et al.
    Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    JAMA 2018;320:2429-2437.

  4. Lentle B, Koromani F, Brown J, Oei L, et al.
    The Radiology of Osteoporotic Vertebral Fractures Revisited.
    J Bone Miner Res 2019.

  5. Iorgulescu JB, Torre M, Harary M, Smith TR, et al.
    The Misclassification of Diffuse Gliomas: Rates and Outcomes.
    Clin Cancer Res 2019.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016